Literature DB >> 23129046

Prospective study of the Wilson severity-of-illness scoring system for complicated skin and skin structure infections.

George H Talbot1, Tanya O'Neal, Anita F Das, Dirk Thye.   

Abstract

Wilson et al. (Am. J. Surg. 185:369-375, 2003) developed a disease severity classification system for use in complicated skin and skin structure infections (cSSSI). Two phase 3 trials of ceftaroline fosamil in cSSSI provided the opportunity to evaluate the association between Wilson Severity Risk Class and clinical cure rates. Our analyses did not confirm that an association exists between Wilson Severity Risk Class and clinical cure rate and, thus, did not validate its predictive utility.

Entities:  

Mesh：

Substances：

Year:  2012        PMID： 23129046      PMCID： PMC3535957          DOI： 10.1128/AAC.01344-12

Source DB:  PubMed          Journal:  Antimicrob Agents Chemother        ISSN： 0066-4804            Impact factor:   5.191


  10 in total

1.  Managing skin and soft tissue infections: expert panel recommendations on key decision points.

Authors:  Lawrence J Eron; Benjamin A Lipsky; Donald E Low; Dilip Nathwani; Alan D Tice; Gregory A Volturo
Journal:  J Antimicrob Chemother       Date:  2003-11       Impact factor: 5.790

2.  FOCUS 2: a randomized, double-blinded, multicentre, Phase III trial of the efficacy and safety of ceftaroline fosamil versus ceftriaxone in community-acquired pneumonia.

Authors:  Donald E Low; Thomas M File; Paul B Eckburg; George H Talbot; H David Friedland; Jon Lee; Lily Llorens; Ian A Critchley; Dirk A Thye
Journal:  J Antimicrob Chemother       Date:  2011-04       Impact factor: 5.790

3.  FOCUS 1: a randomized, double-blinded, multicentre, Phase III trial of the efficacy and safety of ceftaroline fosamil versus ceftriaxone in community-acquired pneumonia.

Authors:  Thomas M File; Donald E Low; Paul B Eckburg; George H Talbot; H David Friedland; Jon Lee; Lily Llorens; Ian A Critchley; Dirk A Thye
Journal:  J Antimicrob Chemother       Date:  2011-04       Impact factor: 5.790

4.  CANVAS 2: the second Phase III, randomized, double-blind study evaluating ceftaroline fosamil for the treatment of patients with complicated skin and skin structure infections.

Authors:  Mark H Wilcox; G Ralph Corey; George H Talbot; Dirk Thye; David Friedland; Tanya Baculik
Journal:  J Antimicrob Chemother       Date:  2010-11       Impact factor: 5.790

5.  CANVAS 1: the first Phase III, randomized, double-blind study evaluating ceftaroline fosamil for the treatment of patients with complicated skin and skin structure infections.

Authors:  G Ralph Corey; Mark H Wilcox; George H Talbot; Dirk Thye; David Friedland; Tanya Baculik
Journal:  J Antimicrob Chemother       Date:  2010-11       Impact factor: 5.790

6.  Prospective study of severity assessment and management of acute medical admissions with skin and soft tissue infection.

Authors:  Charis Marwick; Nikolas Rae; Nicola Irvine; Peter Davey
Journal:  J Antimicrob Chemother       Date:  2012-01-09       Impact factor: 5.790

7.  A prediction rule to identify low-risk patients with community-acquired pneumonia.

Authors:  M J Fine; T E Auble; D M Yealy; B H Hanusa; L A Weissfeld; D E Singer; C M Coley; T J Marrie; W N Kapoor
Journal:  N Engl J Med       Date:  1997-01-23       Impact factor: 91.245

8.  Integrated analysis of CANVAS 1 and 2: phase 3, multicenter, randomized, double-blind studies to evaluate the safety and efficacy of ceftaroline versus vancomycin plus aztreonam in complicated skin and skin-structure infection.

Authors:  G Ralph Corey; Mark Wilcox; George H Talbot; H David Friedland; Tanya Baculik; Gary W Witherell; Ian Critchley; Anita F Das; Dirk Thye
Journal:  Clin Infect Dis       Date:  2010-09-15       Impact factor: 9.079

9.  A severity score for complicated skin and soft tissue infections derived from phase III studies of linezolid.

Authors:  Samuel Eric Wilson; Joseph S Solomkin; Vu Le; Sue K Cammarata; Jon B Bruss
Journal:  Am J Surg       Date:  2003-04       Impact factor: 2.565

10.  Severity assessment of skin and soft tissue infections: cohort study of management and outcomes for hospitalized patients.

Authors:  Charis Marwick; Janice Broomhall; Colin McCowan; Gabby Phillips; Sebastian Gonzalez-McQuire; Kasem Akhras; Sanjay Merchant; Dilip Nathwani; Peter Davey
Journal:  J Antimicrob Chemother       Date:  2010-10-05       Impact factor: 5.790
  10 in total
  2 in total

1.  Early Response in Cellulitis: A Prospective Study of Dynamics and Predictors.

Authors:  Trond Bruun; Oddvar Oppegaard; Karl Ove Hufthammer; Nina Langeland; Steinar Skrede
Journal:  Clin Infect Dis       Date:  2016-07-11       Impact factor: 9.079

2.  Ceftaroline Fosamil for the Empiric Treatment of Hospitalized Adults with cSSTI: An Economic Analysis from the Perspective of the Spanish National Health System.

Authors:  Antoni Torres; Alex Soriano; Simone Rivolo; Edit Remak; Carmen Peral; Michal Kantecki; Wajeeha Ansari; Claudie Charbonneau; Jennifer Hammond; Santiago Grau; Mark Wilcox
Journal:  Clinicoecon Outcomes Res       Date:  2022-03-18
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.